Please login to the form below

UK biotech

This page shows the latest UK biotech news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s head of pharma heads for the exit

Carine Bruillon. Recent deals have included a 325m acquisition of AMAL Therapeutics to gain access to its cancer vaccine technology, a $226m alliance with UK-listed biotech PureTech Health to develop

Latest news

Finch Therapeutics bags $53m for microbiome therapies

The biotech is currently enrolling a phase 2 study evaluating the safety and efficacy of its therapy in adults with ASD. ... Last June, Roche’s biotech division Genentech signed a $534m deal with UK biotech Microbiotica, to access its precision
Boehringer posts solid first half as business revamp beds in

Last month for example it signed a 325m deal to acquire AMAL Therapeutics to gain access to its cancer vaccine technology, and in April forged a $226m alliance with UK-listed ... biotech PureTech Health to develop a new approach to cancer immunotherapy.
Still no ferry contracts for no-deal Brexit medicines supplies

The government says this will cover freight transport, warehousing and stockpiling of medicines – nevertheless the UK Biotech Industry Association (BIA) say many of the most vital preparations are still not in ... EMIG, the UK industry group which
Life sciences and NHS feature in Johnson speech – but Brexit promises predominate

Above all, however, the UK pharma and biotech sectors wants to see a no-deal Brexit avoided – but that is one promise that the new PM is not prepared to make. ... deep regulatory and scientific co-operation between the UK and EU," she said.
Illumina sets up first ex-US accelerator site in Cambridge

Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for ... Thereafter the UK accelerator will run two six-month funding cycles each year.

More from news
Approximately 22 fully matching, plus 153 partially matching documents found.

Latest Intelligence

Building Europe’s next breakthrough biotechs

How can the UK life science ecosystem produce even more biotech start-ups, and propel them to long-term success? ... Its founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Roche's
25 Women Leaders in UK Healthcare

genetic research through to drug development in pharma, and into leadership of several successful UK biotech firms. ... That’s why Theodora Hall taking on the top job at emerging UK biotech Crescendo Biologics is worth noting, as she represents a new
Unlocking the potential of science and technology in the UK

One of most eye-catching developments in UK biotech this year saw the start-up Ziylo acquired in a deal worth up to £623m by Novo Nordisk, a global leader in ... The UK has one of most productive health and life sciences sectors in the world.
Diversity and inclusion in the pharma industry

thisarea, they would also agree that recent UK GPG reporting addresses only one small part of the inequality challenge. ... Gender pay gap: not an equal paying ground. Regulatory driven though it may be, GPG reporting provides a snapshot of gender
30 Women Leaders in UK Healthcare (part 2)

Until earlier this year she was the Chief Business Officer at Immunocore (since 2013), one of the most hotly-tipped UK biotech companies in the field of immunotherapy. ... 19. Kate Bingham, Managing Partner, SV Life Sciences. Kate is one of the

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

F-star hires ex-BMS immuno-oncology leader

New CMO to oversee development of lead candidate. UK biotech F-star has appointed Louis Kayitalire, MD, as its new Chief Medical Officer (CMO), wooing him from a senior role in ... F-star says this newly created management position will be crucial
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Latest movers in pharma and biotech. Immunocore names new CEO. Bahija Jallal, Immunocore's next CEO. ... Immunotherapy-focused UK biotech company Immunocore has unveiled Bahija Jallal as its new chief executive and director of the board.
Redx poaches AstraZeneca senior executive

Lisa Anson joins the UK biotech as its CEO. Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson. ... substantial biotech company built upon an innovative science base, selectively
Redx Pharma appoints new chief medical officer

Dr Andrew Saunders joins the UK biotech from Lytix Biopharma. Drug discovery and development group Redx Pharma has appointed Dr Andrew Saunders as its chief medical officer (CMO), a role that ... He joins the UK biotech from Lytix Biopharma, a Norweigan
Glythera strengthens its scientific advisory board and appoints CSO

Dr Robert Lutz and Dr Jon Roffey join the UK biotech. ... Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio.

More from appointments
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest from PMHub

Lucid bolsters its senior leadership team

Shula began working in medical communications in the USA following a successful research career in academia and the biotech industry in the UK, Germany and the USA. ... Coming back to the UK after 13 happy and successful years in America has given me the

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Events Executive: DOE

Senior Medical Writer: Competitive salary plus benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Client Services Director- Flexible Working: Negotiable

Account Manager – Healthcare advertising: Salary TBC

Account Director – UK Office: Excellent salary and benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...